BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2001
View Archived Issues
Valentis highlights significant events over past year
Read More
Innogenetics updates product pipeline
Read More
FDA approves TAP's Spectracef
Read More
Devgen and Metabolex work together in the area of diabetes
Read More
U.S. Ethyol rights to be returned to MedImmune by October 1, 2001
Read More
deCODE locates genes linked to obesity and anxiety in a collaboration with Roche
Read More
ATL-193 and ATL-146e as pharmacological stress agents for myocardial perfusion imaging
Read More
Non-nucleoside-containing tricyclic platelet P2Y12 receptor antagonist characterized
Read More
Thirty-six-week follow-up data show maintenance of weight loss after treatment with Axokine
Read More
Potential new drug for removing cholesterol licensed to Samaritan
Read More
AERx iDMS showcased at EASD meeting
Read More
Men with diabetes-related ED respond well to on-demand treatment with IC-351
Read More
Oncolytics Biotech continues to make progress with reovirus as cancer therapy
Read More
Ferrochloroquine: high antimalarial activity coupled with lack of significant crossresistance
Read More
Procyon highlights Q2 developments
Read More
Fourth human beta-defensin peptide identified and characterized
Read More
Norwegian collaboration focuses on human antibodies for infectious diseases
Read More
PhotoCure prepares for Metvix launch; Hexvix development progressing as planned
Read More
Enrollment completed in pivotal Alzheimer's disease trial of Neotrofin
Read More
Myriad Genetics highlights development progress
Read More
Adapalene and pharmaceutical compositions thereof for use in cancer therapy
Read More
New ribozyme modulates CHK1 gene expression
Read More
Spiro protein farnesyltransferase inhibitors designed by Merck scientists
Read More
Novel PDE4 and TNF-alpha inhibitors in the Pfizer pipeline
Read More
Recent patent covers hydroxamic acid-based inhibitors of sCD23
Read More
Merck Frosst/AxyS collaboration identifies new cathepsin inhibitors
Read More
